Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.

Date publication

septembre 2023

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BORG Christophe , Pr BOUCHE Olivier , Pr LEPAGE Côme , Dr VERNEREY Dewi , Mr FALCOZ Antoine

Tous les auteurs :
Rasola C, Laurent-Puig P, André T, Falcoz A, Lepage C, Aparicio T, Bouché O, Lievre A, Mineur L, Bennouna J, Louvet C, Bachet JB, Borg C, Vernerey D, Lonardi S, Taieb J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37797388

Résumé

It is intuitively thought that early relapse is associated with poor survival after recurrence (SAR) in resected colon cancer (CC) patients, but this has never been formally studied.

Mots clés

Adjuvant, BRAF(V600E) mutation, MSI/dMMR, RAS mutation, Stage III colon cancer, Survival after relapse, Time to recurrence

Référence

Eur J Cancer. 2023 09 9;194:113321